[1]李玉芳,李正达,郭艳霞,等.ROX指数预测流感相关肺炎患者气管插管的有效性分析[J].医学信息,2022,35(05):131-133.[doi:10.3969/j.issn.1006-1959.2022.05.034]
　LI Yu-fang,LI Zheng-da,GUO Yan-xia,et al.Effect of ROX Index in Predicting Tracheal Intubation in Patients with Influenza-related Pneumonia[J].Medical Information,2022,35(05):131-133.[doi:10.3969/j.issn.1006-1959.2022.05.034]
点击复制

ROX指数预测流感相关肺炎患者气管插管的有效性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年05期
页码:
131-133
栏目:
临床研究
出版日期:
2022-03-01

文章信息/Info

Title:
Effect of ROX Index in Predicting Tracheal Intubation in Patients with Influenza-related Pneumonia
文章编号:
1006-1959（2022）05-0131-03
作者:
李玉芳; 李正达; 郭艳霞; 等
（苏州大学附属第一医院重症医学科，江苏 苏州 215000）
Author(s):
LI Yu-fang; LI Zheng-da; GUO Yan-xia; et al.
(Department of Critical Care Medicine,the First Affiliated Hospital of Suzhou University,Suzhou 215000,Jiangsu,China)
关键词:
流感相关肺炎; ROX指数; 经鼻高流量氧疗
Keywords:
Influenza-related pneumonia; ROX index; High flow nasal cannula therapy
分类号:
R511.7
DOI:
10.3969/j.issn.1006-1959.2022.05.034
文献标志码:
A
摘要:
目的 探讨ROX指数预测流感相关肺炎患者气管插管的有效性。方法 选取2018年12月1日-2020年2月15日苏州大学附属第一医院经鼻高流量氧疗治疗的流感相关肺炎患者47例作为研究对象，根据患者是否进行气管插管，将其分为未插管组30例和插管组17例。比较两组一般资料，并采用多因素Logistic回归分析气管插管的独立显著预测因子；采用受试者工作曲线（ROC）确定最佳的气管插管预测截断值。结果 单因素分析显示，插管组与未插管组在BMI、甲型流感、淋巴细胞计数、白细胞计数、血小板计数、降钙素原、高血压史、糖尿病史、心率、PO2比较，差异无统计学意义（P＞0.05）；两组性别、年龄、APACHEⅡ评分、CRP、ROX指数比较，差异有统计学意义（P＜0.05）。多因素Logistic回归分析显示，ROX指数是气管插管独立保护因素[β=-0.470，AOR（95%CI）：0.630（0.400~0.980），P=0.041]。ROC曲线分析显示，ROX指数预测的曲线下面积为0.871（95%CI：0.765~0.976），最佳截断值为5.04，灵敏度为90.02%，特异度为70.62%。结论 ROX指数对预测流感相关肺炎患者经鼻高流量氧疗中气管插管的准确性较高，有助于临床对该疾病的诊断。
Abstract:
Objective To investigate the effect of ROX index in predicting tracheal intubation in patients with influenza-associated pneumonia.Methods A total of 47 patients with influenza-associated pneumonia treated by nasal high flow oxygen therapy in the First Affiliated Hospital of Suzhou University from December 1, 2018 to February 15, 2020 were selected as the research objects. According to whether the patients were subjected to tracheal intubation, they were divided into the non-intubation group (n=30) and the intubation group (n=17). The general data were compared, and the independent predictors of tracheal intubation were analyzed by multivariate Logistic regression. The optimal cut-off value of tracheal intubation was determined by receiver operating curve (ROC).Results Univariate analysis showed that there was no significant difference in BMI, influenza A, lymphocyte count, white blood cell count, platelet count, procalcitonin, hypertension history, diabetes history, heart rate and PO2 between the intubation group and the non-intubation group (P>0.05); there were significant differences in gender, age, APACHEⅡ score, CRP and ROX index between the two groups (P<0.05). Multivariate logistic regression analysis showed that ROX index was an independent protective factor for tracheal intubation [β=-0.470, AOR(95%CI): 0.630 (0.400-0.980), P=0.041]. ROC curve analysis showed that the area under the curve predicted by the ROX index was 0.871 (95%CI: 0.765-0.976), the optimal truncation value was 5.04, the sensitivity was 90.02%, and the specificity was 70.62%.Conclusion ROX index has high accuracy in predicting tracheal intubation in patients with influenza-associated pneumonia undergoing nasal high flow oxygen therapy, which is helpful for clinical diagnosis of the disease.

参考文献/References:

[1]Iuliano AD,Roguski KM,Chang HH,et al.Estimates of global seasonal influenza-associated respiratory mortality: a modelling study[J].The Lancet,2018,391(10127):1285-1300.[2]Xu J,Yu J,Yang L,et al.Influenza Virus in Community-Acquired Pneumonia: Current Understanding and Knowledge Gaps[J].Semin Respir Crit Care Med,2020,41(4):555-567.[3]Li L,Liu Y,Wu P,et al.Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study[J].The Lancet Public Health,2019,4(9):e473-e481.[4]Wu S,Wei Z,Greene CM,et al.Mortality burden from seasonal influenza and 2009 H1N1 pandemic influenza in Beijing,China,2007-2013[J].Influenza Other Respir Viruses,2018,12(1):88-97.[5]Boyd M,Clezy K,Lindley R,et al.Pandemic influenza: clinical issues[J].Med J Aust,2006,185(S10):S44-S47.[6]Chen L,Han X,Li YL,et al.FluA-p score: a novel prediction rule for mortality in influenza A-related pneumonia patients[J].Respir Res,2020,21(1):109.[7]Roca O,Caralt B,Messika J,et al.An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy[J].Am J Respir Crit Care Med,2019,199(11):1368-1376.[8]Roca O,Messika J,Caralt B,et al.Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index[J].J Crit Care,2016(35):200-205.[9]笪伟,何媛媛,王晓波,等.ROX指数对新型冠状病毒肺炎患者经鼻高流量湿化氧疗疗效的评估价值[J].中华急诊医学杂志,2021,30(5):588-592.[10]Frat JP,Thille AW,Mercat A,et al.High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure[J].N Engl J Med,2015,372(23):2185-2196.[11]Drake MG.High-Flow Nasal Cannula Oxygen in Adults: An Evidence-based Assessment[J].Ann Am Thorac Soc,2018,15(2):145-155.[12]Messika J,Ben Ahmed K,Gaudry S,et al.Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study[J].Respir Care,2015,60(2):162-169.[13]Kang BJ,Koh Y,Lim CM,et al.Failure of high-flow nasal cannula therapy may delay intubation and increase mortality[J].Intensive Care Med,2015,41(4):623-632.[14]Nicolini A,Tonveronachi E,Navalesi P,et al.Effectiveness and predictors of success of noninvasive ventilation during H1N1 pandemics: a multicenter study[J].Minerva Anestesiol,2012,78(12):1333-1340.[15]Goh KJ,Chai HZ,Ong TH,et al.Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate[J].J Intensive Care,2020(8):41.[16]Sztrymf B,Messika J,Bertrand F,et al.Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study[J].Intensive Care Med,2011,37(11):1780-1786.[17]Duan J,Han X,Bai L,et al.Assessment of heart rate,acidosis,consciousness,oxygenation,and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients[J].Intensive Care Med,2017,43(2):192-199.[18]Suttapanit K,Boriboon J,Sanguanwit P.Risk factors for non-invasive ventilation failure in influenza infection with acute respiratory failure in emergency department[J].Am J Emerg Med,2021(45):368-373.[19]Chandel A,Patolia S,Brown AW,et al.High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success[J].Respir Care,2021,66(6):909-919.[20]Lee CU,Jo YH,Lee JH,et al.The index of oxygenation to respiratory rate as a prognostic factor for mortality in Sepsis[J].Am J Emerg Med,2021(45):426-432.[21]Lemiale V,Dumas G,Demoule A,et al.Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure[J].Ann Intensive Care,2021,11(1):17.[22]Hill NS,Ruthazer R.Predicting Outcomes of High-Flow Nasal Cannula for Acute Respiratory Distress Syndrome.An Index that ROX[J].Am J Respir Crit Care Med,2019,199(11):1300-1302.

更新日期/Last Update: 1900-01-01